GlassScriptPhysician profile
Laura Ashley Ray
NPI 1124355086
$1,119.23
in general payments reported to CMS, 2019-2025
25 companies · $342 in 2025
The $342 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $192 · 2022: $113 · 2023: $268 · 2024: $204 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $677 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $677.20 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $172.03 | 2023 | Stratafix |
| Merck Sharp & Dohme LLC | $151.44 | 2022-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Myriad Genetic Laboratories, INC. | $144.70 | 2021-2025 | Myrisk |
| Hologic INC | $84.50 | 2021 | |
| Stryker Corporation | $71.70 | 2025 | Molli, Eikon, Spy-Phi System |
| Molli Surgical (US) INC | $60.93 | 2024 | |
| Axogen | $38.54 | 2025 | |
| Allergan, INC. | $34.87 | 2021-2022 | |
| Innocoll Pharmaceuticals Limited | $33.98 | 2021-2022 | |
| Boston Scientific Corporation | $28.20 | 2022 | |
| Elucent Medical | $24.22 | 2025 | |
| Solventum Corporation | $23.97 | 2025 | V.A.C.Ulta, Prevena |
| Novartis Pharmaceuticals Corporation | $23.57 | 2024 | |
| Janssen Biotech, INC. | $23.51 | 2023 | Stelara |
| Astrazeneca Pharmaceuticals LP | $22.94 | 2025 | Enhertu |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $22.20 | 2023 | Verzenio |
| Abbvie INC. | $20.98 | 2022 | |
| Alexion Pharmaceuticals, INC. | $20.33 | 2025 | Ultomiris |
| Baxter Healthcare | $19.73 | 2024 | Perclot |
| Kci USA, INC. | $17.60 | 2021 | |
| Merit Medical Systems INC | $17.19 | 2021 | |
| Medtronic, INC. | $16.90 | 2023 | Plasmablade(Tm) |
| Bayer Healthcare Pharmaceuticals INC. | $16.71 | 2024 | |
| Ethicon US, LLC | $14.58 | 2023 | Vistaseal, Monocryl, Dermabond Prineo |
| W. L. Gore & Associates, INC. | $13.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Ray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.